Letter from the Director: Understanding the H1N1 Virus

Originally published in LabTalk (Volume 4, Issue 3, 2009), the quarterly newsletter of Aculabs. Novel H1N1 virus, known to be an influenza A-subtype, was originally referred to as “swine flu” because it is very similar to influenza viruses normally occurring in North American pigs (swine). Flu viruses are mainly spread from person to person through

By |2018-09-19T12:14:19-04:00September 30th, 2009|Categories: Quarterly Letter|0 Comments

Letter from the Director: Accurate Diagnosis Benefits of 25-Hydroxyvitamin D

Originally published in LabTalk (Volume 4, Issue 2, 2009), the quarterly newsletter of Aculabs. Vitamin D has been well known for its role in bone metabolism; however, the important role of vitamin D beyond that was the discovery of the 1,25-Dihydroxyvitamin D nuclear receptor in most tissue. Increased interest in vitamin D introduced the recent

By |2018-07-26T15:56:37-04:00June 30th, 2009|Categories: Quarterly Letter|0 Comments

Letter from the Director: High Sensitivity C-Reactive Protein & Statin Treatments

Originally published in LabTalk (Volume 4, Issue 1, 2009), the quarterly newsletter of Aculabs. JUPITER (Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin), a study published in the Nov. 20 edition of New England Journal of Medicine, showed that treatment with Statin could significantly reduce cardiovascular problems in apparently

By |2018-09-19T12:11:01-04:00January 31st, 2009|Categories: Quarterly Letter|0 Comments
Go to Top